iShares Biotechnology ETF (NASDAQ:IBB) Shares Sold by Pacific Capital Wealth Advisors Inc.

Pacific Capital Wealth Advisors Inc. decreased its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 17.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 52,248 shares of the financial services provider’s stock after selling 11,136 shares during the quarter. iShares Biotechnology ETF comprises 1.2% of Pacific Capital Wealth Advisors Inc.’s holdings, making the stock its 15th largest holding. Pacific Capital Wealth Advisors Inc. owned approximately 0.11% of iShares Biotechnology ETF worth $6,908,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Hsbc Holdings PLC lifted its position in iShares Biotechnology ETF by 47.1% in the second quarter. Hsbc Holdings PLC now owns 3,670 shares of the financial services provider’s stock valued at $504,000 after buying an additional 1,175 shares during the last quarter. Bank of Montreal Can lifted its holdings in shares of iShares Biotechnology ETF by 2.6% in the 2nd quarter. Bank of Montreal Can now owns 36,198 shares of the financial services provider’s stock worth $5,086,000 after acquiring an additional 920 shares during the last quarter. Creative Planning boosted its position in shares of iShares Biotechnology ETF by 2.9% during the 2nd quarter. Creative Planning now owns 67,902 shares of the financial services provider’s stock worth $9,320,000 after purchasing an additional 1,905 shares during the period. NewEdge Advisors LLC increased its holdings in iShares Biotechnology ETF by 20.1% in the 2nd quarter. NewEdge Advisors LLC now owns 11,633 shares of the financial services provider’s stock valued at $1,597,000 after purchasing an additional 1,944 shares during the last quarter. Finally, B. Riley Wealth Advisors Inc. raised its position in iShares Biotechnology ETF by 2.0% in the second quarter. B. Riley Wealth Advisors Inc. now owns 11,722 shares of the financial services provider’s stock valued at $1,609,000 after purchasing an additional 229 shares during the period. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

IBB opened at $138.37 on Tuesday. iShares Biotechnology ETF has a 52 week low of $123.60 and a 52 week high of $150.57. The business has a fifty day simple moving average of $136.15 and a 200-day simple moving average of $141.77.

iShares Biotechnology ETF Cuts Dividend

The company also recently announced a dividend, which was paid on Friday, December 20th. Investors of record on Tuesday, December 17th were issued a dividend of $0.0624 per share. The ex-dividend date was Tuesday, December 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.